Allied Market Research


Medical Marijuana Market

Medical Marijuana Market Size, Share, Competitive Landscape and Trend Analysis Report by Medical Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Marijuana refers to the dried leaves, flowers, stems, and seeds from the hemp plantCannabis sativa. There are 2 main active chemicals in Marijuanacannabidiol (CBD) and tetrahydocannabinol (THC), which impact the brain and relieve the pain, respectively. Marijuana provides pain relief in conditions such as fibromyalgia, grand mal seizures, and other medical conditions. Similarly, it reduces symptoms of many serious medical conditions such as AIDS, cancer, and glaucoma.

The increase in prevalence of diseases and growth in demand for relieving pain in conditions such as cancer, AIDS, seizures, and other diseases majorly drive the medical marijuana market. In 2016, countries such as Colombia, Macedonia, Israel, Germany, Australia, and others allowed the medical use of marijuana.

Thus, rise in number of countries legalizing the use of medical marijuana is anticipated to fuel the growth of the market during the forecast period. Furthermore, the stringent rules and regulations associated with the medical marijuana such as Medical Marijuana Regulation and Safety Act and increase in number of license issued every year stipulates demand of Marijuana in market.

Moreover, growth in investment in R&D and increase in business strategies by companies of marijuana is expected to impel the market growth. For instance, in 2016, Gibraltar Industries acquired Nexus Corporation strengthening its position as greenhouse manufacturer and distributor. However, complex regulatory framework to obtain license majorly hinders the medical marijuana market.

The market is segmented on the basis of medical application and geography. By medical applications, the market is categorized into chronic pain, migraine, cancer, arthritis, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • The study provides an in-depth analysis of the global medical marijuana market, with current trends and future estimations to elucidate the investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of different segments facilitates to understand various products of the market.
  • Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

Medical Marijuana Market Report Highlights

Aspects Details
By Medical Application
  • Chronic Pain
  • Migraine
  • Cancer
  • Arthritis
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

GW Pharmaceuticals, plc, Cannabis Sativa, Inc., Arena Pharmaceuticals, Cara Therapeutics Inc., Aphria, CannaGrow Holdings, Inc., Canopy Growth, Lexaria Corp, International Consolidated Companies, Inc., Insys Therapeutics

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Medical Marijuana Market

Global Opportunity Analysis and Industry Forecast, 2023-2032